000919 金陵药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.2673.3023.5564.1702.271
总资产报酬率 ROA (%)0.8802.1912.3422.7631.543
投入资产回报率 ROIC (%)1.2353.1763.3793.9792.192

边际利润分析
销售毛利率 (%)22.75821.04019.77322.43222.422
营业利润率 (%)8.1634.2004.8687.0205.004
息税前利润/营业总收入 (%)7.7383.4424.0646.2904.509
净利润/营业总收入 (%)6.3183.8484.2635.4453.741

收益指标分析
经营活动净收益/利润总额(%)98.91575.17955.03695.999148.084
价值变动净收益/利润总额(%)4.35214.054-9.568-1.358-10.988
营业外收支净额/利润总额(%)0.3501.202-1.755-1.211-0.122

偿债能力分析
流动比率 (X)3.7302.7593.0432.6742.560
速动比率 (X)3.4282.4402.7532.3872.291
资产负债率 (%)16.25919.02120.18620.5300.199
带息债务/全部投入资本 (%)1.4651.9793.1463.2992.264
股东权益/带息债务 (%)6,668.7854,910.4173,026.2892,875.4214,242.021
股东权益/负债合计 (%)440.701351.512326.399320.638336.004
利息保障倍数 (X)-17.042-4.252-5.643-9.738-9.218

营运能力分析
应收账款周转天数 (天)48.90937.68739.49340.49841.574
存货周转天数 (天)40.61642.43441.66138.08041.648